Literature DB >> 17209223

Breast cancer and the risk of osteoporotic fracture: A paradox.

Richard Eastell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17209223     DOI： 10.1210/jc.2006-2437

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Soy isoflavone intake and bone mineral density in breast cancer survivors.

Authors:  Michelle L Baglia; Kai Gu; Xianglan Zhang; Ying Zheng; Peng Peng; Hui Cai; Ping-Ping Bao; Wei Zheng; Wei Lu; Xiao-Ou Shu
Journal:  Cancer Causes Control       Date:  2015-02-17       Impact factor: 2.506

2.  Bone health history in breast cancer patients on aromatase inhibitors.

Authors:  Marilyn L Kwan; Joan C Lo; Li Tang; Cecile A Laurent; Janise M Roh; Malini Chandra; Theresa E Hahn; Chi-Chen Hong; Lara Sucheston-Campbell; Dawn L Hershman; Charles P Quesenberry; Christine B Ambrosone; Lawrence H Kushi; Song Yao
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

Review 3.  Potential role of odanacatib in the treatment of osteoporosis.

Authors:  Kong Wah Ng
Journal:  Clin Interv Aging       Date:  2012-07-12       Impact factor: 4.458
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.